Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).

Omega Medical Imaging Launches AI-enabled FluoroShield for Radiation Reduction
Technology | Radiation Dose Management
Omega Medical Imaging Launches AI-enabled FluoroShield for Radiation Reduction

April 4, 2019 — The U.S. Food and Drug Administration (FDA) granted Omega Medical Imaging 510(k) clearance to offer ...

Home April 04, 2019
Home
Evolut Low Risk Trial compared the minimally invasive Evolut transcatheter aortic valve replacement (TAVR) system to the gold standard of open-heart surgery in characteristically younger, healthier aortic stenosis patients. The randomized trial, which met its primary non-inferiority endpoint of all-cause mortality or disabling stroke at two years compared to surgery (5.3 vs. 6.7 percent; posterior probability of non-inferiority >0.999), was presented at the American College of Cardiology (ACC) 2019 meeting
News | Heart Valve Technology
TAVR Performs Well Compared to Surgical Aortic Valve Replacement in Low Risk Patients

April 3, 2019 – The ACC.19 late-breaking landmark Evolut Low Risk Trial compared the minimally invasive Evolut ...

Home April 03, 2019
Home
The U.S. Food and Drug Administration (FDA) recently granted an additional indication to Bard Peripheral Vascular's Covera Vascular Covered Stent for the treatment of a stenosis or blockage which has developed anywhere in the access circuit of patients on hemodialysis using an arteriovenous (AV) fistula.
Technology | Stents
New Indication Added for Covered Stent to Treat Hemodialysis AV Fistula

April 3, 2019 — The U.S. Food and Drug Administration (FDA) recently granted an additional indication to Bard Peripheral ...

Home April 03, 2019
Home
The U.S. Food and Drug Administration (FDA) recently cleared Bard Peripheral Vascular's Venovo Venous Stent System intended to treat narrowed iliofemoral veins.
Technology | Venous Therapies
FDA Clears Venous Stent for the Iliofemoral Veins

April 3, 2019 — The U.S. Food and Drug Administration (FDA) recently cleared Bard Peripheral Vascular's Venovo Venous ...

Home April 03, 2019
Home
Essential Medical Inc. received U.S. Food and Drug Administration (FDA) clearance for its large bore Manta Vascular Closure Device. It is designed to close large puncture sites in the femoral artery from larger sized transcatheter devices, including the Impella heart pump, endovascular stent grafts and transcatheter valves.
Technology | Vascular Closure Devices
Large-Bore Vascular Closure Device Cleared by the FDA

April 3, 2019 — Essential Medical Inc. received U.S. Food and Drug Administration (FDA) clearance for its large bore ...

Home April 03, 2019
Home
Medtronic's Resolute Integrity Zotarolimus-eluting Coronary Stent System received an additional U.S. Food and Drug Administration (FDA) indication for treatment of de novo chronic total occlusion (CTO) lesions.
Technology
Resolute Integrity Now Indicated for CTOs

April 3, 2019 — Medtronic's Resolute Integrity Zotarolimus-eluting Coronary Stent System received an additional U.S ...

Home April 03, 2019
Home
The top cardiac technology news item in March was the FDA clearing the MitraClip for use in heart failure patients with functional mitral regurgitation based on the very positive results of the COAPT Trial.
Feature
Most Popular Cardiology Technology Content in March 2019
April 1, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) maga ...
Home April 01, 2019
Home
All major vendors offering advanced visualization software now offer structural heart planning. This is an example of GE Healthcare's Valve Assist software being used to determine the best location of a transseptal puncture to deliver a left atrial appendage (LAA) occluder.
Feature | Structural Heart | Jeff Zagoudis
The Essentials of Structural Heart Imaging
Structural heart interventions represent one of the fastest growing segments of cardiology, as the number of devices to ...
Home March 28, 2019
Home
Videos
VIDEO: The Role of the NCDR in Boosting Cardiology Quality Improvement

Interview with Frederick Masoudi, M.D., FACC, FAHA, professor of cardiology at the University of Colorado Hospital, and ...

Home March 28, 2019
Home
SyncVision iFR Co-registration from Philips Healthcare maps pressure readings onto angiogram. Results from an international study presented at ACC 2019 indicates pressure readings obtained using iFR (instantaneous wave-free ratio, also referred to as instant wave-free ratio or instant flow reserve) in coronary arteries may localize stenoses that remain after interventions. FFR in the cath lab.
Feature | ACC | Greg Freiherr, Contributing Editor
New Technology Highlights on the ACC 2019 Exhibit Floor
The fingerprints of value-added medicine were all over products and works-in-progress on the exhibit floor of the annual ...
Home March 27, 2019
Home
SCAI Offers Recommendations for Safe Use of PFO Closure Technologies. SCAI said completion of the randomized trials demonstrating the superiority of PFO closure and medical therapy over medical therapy alone
News | Structural Heart Occluders
SCAI Offers Recommendations for Safe Use of PFO Closure Technologies

March 27. 2019 — A newly released expert consensus statement provides recommendations for the safe and effective ...

Home March 27, 2019
Home
The Centers for Medicare and Medicaid Services (CMS) proposed to update its national coverage policy for transcatheter aortic valve replacement (TAVR). The current national coverage determination, effective May 1, 2012, established CMS coverage for TAVR under Coverage with Evidence Development (CED). Since the finalization of the 2012 national coverage determination, TAVR programs have been established in more than 500 hospitals across the country.
News | Heart Valve Technology
CMS Proposes Updates for TAVR Coverage

March 27, 2019 — The Centers for Medicare and Medicaid Services (CMS) proposed to update its national coverage policy ...

Home March 27, 2019
Home
Illustration showing the venous implantation route and where the inlet and outflow ports are when the Abiomed Impella RP is placed in the right side of the heart. The Impella RP catheter is used for right heart hemodynamic support.
Feature | Hemodynamic Support Devices | Perwaiz Meraj, M.D. FACC and Uma Chandrasekaran, Ph.D.
Right Heart Hemodynamic Support With Impella RP, Getting it Right

Right heart failure (RHF) is a syndrome characterized by the inability of the right ventricle (RV) to support optimal ...

Home March 26, 2019
Home
Medical video game company Level Ex expanded into cardiology with the launch of Cardio Ex. It offers clinical video game scenarios that aid in cognitive, spatial-reasoning and decision-making skills in the cath lab. Medical video game app for cardiology training.
Technology | Cardiovascular Education
Video Game Format Used to Train Cardiologists

March 26, 2019 — Level Ex, creators of medical video games for physicians, expanded into cardiology with the launch of ...

Home March 26, 2019
Home
Stopping DAPT After One Month Improved Outcomes in Stent Patients
News | Antiplatelet and Anticoagulation Therapies
Stopping DAPT After One Month Improved Outcomes in Stent Patients

March 25, 2019 — Patients who stopped taking aspirin one month after receiving a stent in the heart’s arteries but ...

Home March 25, 2019
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now